Clinical Trial Update: Prevention of Varicella Zoster Virus (VZV)-Reactivation in HIV-positive Individuals Enrolled in a Prospective Immunogenicity and Safety Trial of VZV Vaccine: PROVE-IT-Study [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating a Varicella Zoster Virus vaccine to prevent reactivation in HIV-positive individuals has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Varicella-zoster vaccine (varicella-zoster vaccine)

Snippet

Sponsor: University of Zurich | Conditions: Herpes Zoster | Phase 1, Phase 2 | Status: WITHDRAWN